RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of ...

In a report released yesterday, Jonathan Atkin from RBC Capital maintained a Buy rating on GDS Holdings (GDS – Research Report), with a price ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

Banking industry veteran Patrice DeCorrevont recently took the helm at the Chicago-based institution after nearly a decade ...